The treatment of patients with axial spondyloarthritis (axSpA) is characterized by non-
pharmacological and pharmacological treatment options. It may depend on the type and …

Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease that
predominantly affects the axial skeleton. The advent of biologic drugs has transformed the …

Objective To update the evidence of non-biological treatments for axial spondyloarthritis
(axSpA), as a basis for the 2022 Assessment of SpondyloArthritis international Society …

Diagnosis and management of axial spondyloarthritis (axSpA) has vastly improved over the
past two decades. With advances in the discernment of immunopathogenesis of this …

Axial spondyloarthritis (axSpA) comprises a spectrum of chronic inflammatory manifestations
affecting the axial skeleton and represents a challenge for diagnosis and treatment. Our …

To assess the efficacy and safety of non-biological therapies in patients with axial
spondyloarthritis (axSpA) to inform the update of the Assessment of SpondyloArthritis …

Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …

Two main treatment targets in axial spondyloarthritis (axSpA) could be currently defined:(1)
reduction of inflammation resulting in control of signs and symptoms such as pain and …

Abstract Purpose of Review An overview of how the treatment landscape of axial
spondyloarthritis (axSpA) has shaped our understanding of the disease. Recent Findings …

Axial spondyloarthritis (axSpA) is a chronic and inflammatory rheumatic disease
characterized by pain, structural and functional impairments, and reduced mobility and …